T 2402/10 (Prostaglandin derivatives / Pfizer) of 10.05.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T240210.20120510
- Date of decision
- 10 May 2012
- Case number
- T 2402/10
- Petition for review of
- -
- Application number
- 02009255.7
- IPC class
- A61K 31/557C07C 405/00A61P 27/02
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
- Applicant name
- Pfizer Health AB
- Opponent name
- Breath Limited
Apotex España SL
ALAPIS S.A. - Board
- 3.3.10
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 76(1)
- Keywords
- Amendments (allowable) - no added matter
Novelty (yes)
Inventive step (yes) - solution not obvious
Double patenting (no) - not the same subject-matter - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the main request as filed with the letter dated 9 March 2012 (claim 1) and a description yet to be adapted.